Positive sentinel lymph node biopsy predicts the number of metastatic axillary nodes of breast cancer

Breast

Volumn 18, Issue 4, 2009, Pages 244-247

  Takei, Hiroyuki ^a   Kurosumi, Masafumi ^a   Yoshida, Takashi ^a   Ninomiya, Jun ^a   Ishikawa, Yuko ^a   Hayashi, Yuji ^a   Tozuka, Katsunori ^a   Asakawa, Hideki ^a   Oba, Hanako ^a   Inoue, Kenichi ^a   Tabei, Toshio ^a  

^a SAITAMA CANCER CENTER   (Japan)

Author keywords

Breast cancer; Number of metastatic axillary nodes; Sentinel lymph node biopsy

Indexed keywords

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME;

ADULT; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENTINEL LYMPH NODE BIOPSY;

EID: 69749108849     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2009.05.007     Document Type: Article

References (26)

1. Witterkind C., Greene F.L., Hutter R.V.P., Klimpfinger M., and Sobin L.H. TNM Atlas. 5th ed. Illustrated guide to the TNM/pTNM classification of malignant tumours (2004), Springer, Berlin pp. 207-23
2. Goldhirsch A., Wood W.C., Gelber R.D., Coates A.S., Thürlimann B., Senn H.J., and 10th St. Gallen conference. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 18 (2007) 1133-1144
3. Krag D.N., Weaver D.L., Alex J.C., and Fairbank J.T. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2 (1993) 335-340
4. Giuliano A.E., Kirgan D.M., Guenther J.M., and Morton D.L. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220 (1994) 391-401
5. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366 (2005) 2087-2106
6. Kim T., Giuliano A.E., and Lyman G.H. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 106 (2006) 4-16
7. Lyman G.H., Giuliano A.E., Somerfield M.R., Benson III A.B., Bodurka D.C., Burstein H.J., et al. American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23 (2005) 7703-7720
8. Veronesi U., Paganelli G., Viale G., Luini A., Zurrida S., Galimberti V., et al. Sentinel-lymph node biopsy as a staging procedure in breast cancer: update of a randomized controlled study. Lancet Oncol 7 (2007) 983-989
9. Krag D.N., Anderson S.J., Julian T.B., Brown A.M., Harlow S.P., Ashikaga T., et al. National Surgical Adjuvant Breast and Bowel Project. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8 (2007) 881-888
10. Takei H., Kurosumi M., Yoshida T., Ninomiya J., Hagiwara Y., Kamimura M., et al. Current trends of sentinel lymph node biopsy for breast cancer - a surgeon's perspective. Breast Cancer 14 (2007) 362-370
11. Van Zee K.J., Manasseh D.M., Bevilacqua J.L., Boolbol S.K., Fey J.V., Tan L.K., et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10 (2003) 1140-1151
12. Hwang R.F., Krishnamurthy S., Hunt K.K., Mirza N., Ames F.C., Feig B., et al. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 10 (2003) 248-254
13. Rivers A.K., Griffith K.A., Hunt K.K., Degnim A.C., Sabel M.S., Diehl K.M., et al. Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node. Ann Surg Oncol 13 (2006) 36-44
14. Takei H., Suemasu K., Kurosumi M., Uchida K., Igarashi K., Ninomiya J., et al. Sentinel lymph node biopsy without axillary dissection after an intraoperative negative histological investigation in 358 invasive breast cancer cases. Breast Cancer 9 (2002) 344-348
15. Takei H., Suemasu K., Kurosumi M., Horii Y., Ninomiya J., Kamimura M., et al. Added value of the presence of blue nodes or hot nodes in sentinel lymph node biopsy of breast cancer. Breast Cancer 13 (2006) 179-185
16. 99mTc-human serum albumin as a radioactive tracer for sentinel lymph node biopsy in breast cancer. Surg Today 36 (2006) 219-24
17. Kurosumi M., Suemasu K., Tabei T., Inoue K., Matsumoto H., Sugamata N., et al. Relationship between existence of lymphatic invasion in peritumoral breast tissue and presence of axillary lymph node metastasis in invasive ductal carcinoma of the breast. Oncol Rep 8 (2001) 1051-1055
18. Takei H., Suemasu K., Kurosumi M., Horii Y., Ninomiya J., Yoshida M., et al. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer. Breast J 12 Suppl.2 (2006) S157-S164
19. Takei H., Suemasu K., Kurosumi M., Horii Y., Yoshida T., Ninomiya J., et al. Recurrence after sentinel lymph node biopsy with or without axillary lymph node dissection in patients with breast cancer. Breast Cancer 14 (2007) 16-24
20. Alkhatib W., Connor C., and Fang F. Solitary positive sentinel lymph node accompanied by negative sentinel lymph node(s) is predictive of a negative completion axillary lymph node dissection. Am J Surg 194 (2007) 856-859
21. Viale G., Maiorano E., Pruneri G., Mastropasqua M.G., Valentini S., Galimberti V., et al. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg 241 (2005) 319-325
22. Kurosumi M., and Takei H. Significance and problems of histopathological examination and utility of real-time reverse transcriptase-polymerase chain reaction method for the detection of sentinel lymph node metastasis in breast cancer. Breast Cancer 14 (2007) 342-349
23. Fisher B., Anderson S., Bryant J., Margolese R.G., Deutsch M., Fisher E.R., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 (2002) 1233-1241
24. Louis-Sylvestre C., Clough K., Asselain B., Vilcoq J.R., Salmon R.J., Campana F., et al. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. J Clin Oncol 22 (2004) 97-101
25. Mansel R.E., Fallowfield L., Kissin M., Goyal A., Newcombe R.G., Dixon J.M., et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98 (2006) 599-609
26. Rutgers E.J., Meijnen P., Bonnefoi H., and European Organization for Research and Treatment of Cancer Breast Cancer Group. Clinical trials update of the European Organization for Research and Treatment of Cancer Breast Cancer Group. Breast Cancer Res 6 (2004) 165-169